{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:52:12Z","timestamp":1782370332654,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12264-025-01415-2","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:38:24Z","timestamp":1747222704000},"page":"1302-1306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Psilocybin and Obsessive-Compulsive Disorder: Exploring New Therapeutic Horizons"],"prefix":"10.1007","volume":"41","author":[{"given":"Longwei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3415-5612","authenticated-orcid":false,"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"1415_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-019-0102-3","volume":"5","author":"DJ Stein","year":"2019","unstructured":"Stein DJ, Costa DLC, Lochner C, Miguel EC, Reddy YCJ, Shavitt RG. Obsessive-compulsive disorder. Nat Rev Dis Primers 2019, 5: 52.","journal-title":"Nat Rev Dis Primers"},{"key":"1415_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1176\/appi.ajp.2020.20111601","volume":"178","author":"WK Goodman","year":"2021","unstructured":"Goodman WK, Storch EA, Sheth SA. Harmonizing the neurobiology and treatment of obsessive-compulsive disorder. Am J Psychiatry 2021, 178: 17\u201329.","journal-title":"Am J Psychiatry"},{"key":"1415_CR3","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1038\/sj.npp.1301165","volume":"31","author":"BD Greenberg","year":"2006","unstructured":"Greenberg BD, Malone DA, Friehs GM, Rezai AR, Kubu CS, Malloy PF, et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology 2006, 31: 2384\u20132393.","journal-title":"Neuropsychopharmacology"},{"key":"1415_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12135","volume":"8","author":"B Kelmendi","year":"2022","unstructured":"Kelmendi B, Kichuk SA, DePalmer G, Maloney G, Ching THW, Belser A, et al. Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: a case report. Heliyon 2022, 8: e12135.","journal-title":"Heliyon"},{"key":"1415_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/02791072.2014.963754","volume":"46","author":"JA Wilcox","year":"2014","unstructured":"Wilcox JA. Psilocybin and obsessive compulsive disorder. J Psychoactive Drugs 2014, 46: 393\u2013395.","journal-title":"J Psychoactive Drugs"},{"key":"1415_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/02791072.2020.1849879","volume":"53","author":"A Lugo-Radillo","year":"2021","unstructured":"Lugo-Radillo A, Cortes-Lopez JL. Long-term amelioration of OCD symptoms in a patient with chronic consumption of psilocybin-containing mushrooms. J Psychoactive Drugs 2021, 53: 146\u2013148.","journal-title":"J Psychoactive Drugs"},{"key":"1415_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1192\/S0007125000297870","volume":"173","author":"S Saxena","year":"1998","unstructured":"Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry 1998, 173: 26\u201337.","journal-title":"Br J Psychiatry"},{"key":"1415_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1556\/2054.2020.00128","volume":"4","author":"E Jacobs","year":"2020","unstructured":"Jacobs E. A potential role for psilocybin in the treatment of obsessive-compulsive disorder. J Psychedelic Stud 2020, 4: 77\u201387.","journal-title":"J Psychedelic Stud"},{"key":"1415_CR9","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1038\/s41467-023-38695-z","volume":"14","author":"M Biria","year":"2023","unstructured":"Biria M, Banca P, Healy MP, Keser E, Sawiak SJ, Rodgers CT, et al. Cortical glutamate and GABA are related to compulsive behaviour in individuals with obsessive compulsive disorder and healthy controls. Nat Commun 2023, 14: 3324.","journal-title":"Nat Commun"},{"key":"1415_CR10","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/hbm.23408","volume":"38","author":"J Posner","year":"2017","unstructured":"Posner J, Song I, Lee S, Rodriguez CI, Moore H, Marsh R, et al. Increased functional connectivity between the default mode and salience networks in unmedicated adults with obsessive-compulsive disorder. Hum Brain Mapp 2017, 38: 678\u2013687.","journal-title":"Hum Brain Mapp"},{"key":"1415_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-024-07624-5","volume":"632","author":"JS Siegel","year":"2024","unstructured":"Siegel JS, Subramanian S, Perry D, Kay BP, Gordon EM, Laumann TO, et al. Psilocybin desynchronizes the human brain. Nature 2024, 632: 131\u2013138.","journal-title":"Nature"},{"key":"1415_CR12","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","volume":"67","author":"FA Moreno","year":"2006","unstructured":"Moreno FA, Wiegand CB, Keolani Taitano E, Delgado PL. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. J Clin Psychiatry 2006, 67: 1735\u20131740.","journal-title":"J Clin Psychiatry"},{"key":"1415_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/02698811231179801","volume":"37","author":"JN Bonnieux","year":"2023","unstructured":"Bonnieux JN, VanderZwaag B, Premji Z, Garcia-Romeu A, Garcia-Barrera MA. Psilocybin\u2019s effects on cognition and creativity: a scoping review. J Psychopharmacol 2023, 37: 635\u2013648.","journal-title":"J Psychopharmacol"},{"key":"1415_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/00048674241289024","volume":"59","author":"RR Freitas","year":"2025","unstructured":"Freitas RR, Gotsis ES, Gallo AT, Fitzgibbon BM, Bailey NW, Fitzgerald PB. The safety of psilocybin-assisted psychotherapy: a systematic review. Aust N Z J Psychiatry 2025, 59: 128\u2013151.","journal-title":"Aust N Z J Psychiatry"},{"key":"1415_CR15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s12264-025-01351-1","volume":"41","author":"C Lin","year":"2025","unstructured":"Lin C, Wang X, Wang X. Exploring the therapeutic potential of psychedelics in chronic pain management: a new frontier in medicine. Neurosci Bull 2025, 41: 719\u2013722.","journal-title":"Neurosci Bull"},{"key":"1415_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","volume":"177","author":"CM Reiff","year":"2020","unstructured":"Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, et al. Psychedelics and psychedelic-assisted psychotherapy. Am J Psychiatry 2020, 177: 391\u2013410.","journal-title":"Am J Psychiatry"},{"key":"1415_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12264-022-00933-7","volume":"39","author":"YN Yin","year":"2023","unstructured":"Yin YN, Gao TM. Non-hallucinogenic psychedelic analog design: a promising direction for depression treatment. Neurosci Bull 2023, 39: 170\u2013172.","journal-title":"Neurosci Bull"},{"key":"1415_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1600-0447.1977.tb00149.x","volume":"55","author":"E Brandrup","year":"1977","unstructured":"Brandrup E, Vanggaard T. LSD treatment in a severe case of compulsive neurosis. Acta Psychiatr Scand 1977, 55: 127\u2013141.","journal-title":"Acta Psychiatr Scand"},{"key":"1415_CR19","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1038\/npp.2013.150","volume":"38","author":"CI Rodriguez","year":"2013","unstructured":"Rodriguez CI, Kegeles LS, Levinson A, Feng T, Marcus SM, Vermes D, et al. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology 2013, 38: 2475\u20132483.","journal-title":"Neuropsychopharmacology"},{"key":"1415_CR20","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1176\/ajp.144.9.1239b","volume":"144","author":"HL Leonard","year":"1987","unstructured":"Leonard HL, Rapoport JL. Relief of obsessive-compulsive symptoms by LSD and psilocin. Am J Psychiatry 1987, 144: 1239\u20131240.","journal-title":"Am J Psychiatry"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01415-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-025-01415-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01415-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T08:34:26Z","timestamp":1751531666000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-025-01415-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1415"],"URL":"https:\/\/doi.org\/10.1007\/s12264-025-01415-2","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"27 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}